EDESA BIOTECH, INC. Contractual Obligation, to be Paid, Year One
EDESA BIOTECH, INC. (EDSA) had Contractual Obligation, to be Paid, Year One of $840.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInNextTwelveMonths · last filed 2026-08-13
- 2026-06-30: Contractual Obligation, to be Paid, Year One $840.00K.
- 2026-03-31: Contractual Obligation, to be Paid, Year One $874.00K.
- 2025-12-31: Contractual Obligation, to be Paid, Year One $79.50K.
- 2025-09-30: Contractual Obligation, to be Paid, Year One $770.00K.
| Period end | Contractual Obligation, to be Paid, Year One |
|---|---|
| 2026-06-30 | $840.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $874.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $79.50K 10-Q · filed 2026-02-13 |
| 2025-09-30 | $770.00K 10-K · filed 2025-12-12 |
| 2025-06-30 | $34.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $34.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $34.00K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $212.67K 10-K · filed 2024-12-13 |
| 2024-06-30 | $49.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $433.00B 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.54T 10-Q · filed 2024-02-09 |
| 2022-06-30 | $1.18M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $3.87M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $12.00B 10-Q · filed 2022-02-14 |
| 2021-09-30 | $38.00B 10-K · filed 2021-12-28 |
| 2021-06-30 | $1.03T 10-Q · filed 2021-08-13 |
| 2021-03-31 | $1.81M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $4.13M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $4.84M 10-K · filed 2020-12-07 |
| 2020-06-30 | $2.90M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $1.72M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $2.15M 10-Q · filed 2020-02-13 |
| 2019-09-30 | $2.25M 10-KT · filed 2019-12-12 |
| 2019-06-30 | $80.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |